AC regimen
WikiDoc Resources for AC regimen |
Articles |
---|
Most recent articles on AC regimen |
Media |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on AC regimen at Clinical Trials.gov Clinical Trials on AC regimen at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on AC regimen
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on AC regimen Discussion groups on AC regimen Patient Handouts on AC regimen Directions to Hospitals Treating AC regimen Risk calculators and risk factors for AC regimen
|
Healthcare Provider Resources |
Causes & Risk Factors for AC regimen |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]
Synonyms and keywords: AC; AC Regimen; Adriamycin-Cytoxan Regimen; CA Regimen.
Overview
AC regimen refers to a regimen consisting of cyclophosphamide and doxorubicin used in the adjuvant setting for the treatment of breast cancer; also used for the treatment of recurrent and metastatic breast cancer.[1][2]
Regimen
ADoxorubicin (Adriamycin)
CCyclophosphamide
Indications
References
- ↑ "NCI Thesaurus".
- ↑ "R-CHOP - National Cancer Institute".
- ↑ Perez EA, Geeraerts L, Suman VJ, Adjei AA, Baron AT, Hatfield AK; et al. (2002). "A randomized phase II study of sequential docetaxel and doxorubicin/cyclophosphamide in patients with metastatic breast cancer". Ann Oncol. 13 (8): 1225–35. PMID 12181246.